• Contact us about your case
  • Plaquemine Office:
    Phone: 888-725-2477
  • Fax: (225) 687-6398
  • New Orleans Office:
    Phone: 504-355-0086
  • Fax: (504) 523-0699

Lipitor Linked To Increase Risk Of Diabetes In Women

March 27th, 2013

Lipitor, a cholesterol lowering statin medication, and its generic version atorvastatin have been linked to an increased risk for diabetes in women. Studies found that women aged of 50 to 79, who were taking Lipitor or the generic atorvastatin, were at a higher risk of developing Type 2 diabetes. Lipitor is produced and sold by Pfizer a pharmaceutical company. A medication label change and health advisory by the FDA in 2012, required Pfizer to update Lipitor’s label to include the... Read More

Posted in Current Cases, firm-news |

Stryker Hip Implant Recall of Rejuvenate Modular and ABG II Devices

February 19th, 2013

Stryker Corporation announced the recall of its Rejuvenate Modular and ABG II modular neck hip stems in July of 2012. Stryker warns that fretting and corrosion due to abrasive wear could lead to corrective hip revision surgery. This fretting and corrosion could lead to the following problems: Metallosis (Metal poisoning caused by release of metal ions into the blood stream and tissue) Pain or swelling in the leg, hip or groin Osteolysis (bone dissolution) Broken or loosened implants Necrosis (premature... Read More

Posted in Current Cases, firm-news |

Pendley, Baudin & Coffin and Baum, Hedlund, Aristei & Goldman to pursue class action litigation against Pfizer, Inc. to address the lack of efficacy in Zoloft

January 31st, 2013

A consumer fraud class action complaint against Pfizer, Inc. has been filed by a California woman who claims that the company falsely and unlawfully marketed its antidepressant drug Zoloft as a highly effective treatment for depression and other mood disorders, knowing that the drug’s effectiveness was similar to that of a sugar pill. Pendley, Baudin & Coffin and Baum, Hedlund, Aristei & Goldman filed the lawsuit on behalf of their client, Laura Plumlee, a housewife and mother of two, who... Read More

Posted in Current Cases, firm-news |

United American Insurance Company Accused of Denial of Benefits

October 15th, 2012

Policyholders of United American Insurance Company’s limited benefit insurance policies complain of misconduct and denial of insurance.  United American Insurance Company has been accused of marketing their limited benefit insurance policies as equal to or better than major medical health insurance.  United American recently entered into a class action settlement to resolve some, but not all of these complaints.  Policyholders still complain that United American Insurance Company continues to fail to pay proper benefits under hospital and surgical expense policies. ... Read More

Posted in Current Cases, firm-news |

BP OIL SPILL SETTLEMENT – Deepwater Horizon Economic and Property Damage Settlement Claims

October 11th, 2012

The federal court overseeing the BP Oil Spill Litigation in New Orleans approved a settlement to pay claims,  including those of businesses who submit qualifying economic loss claims.  The Gulf Coast Claims Facility (GCCF) has closed its doors and the Deepwater Horizon Economic and Property Damage Settlement Claims Program is processing claims. If your BP claim has been denied by the GCCF, if you need help with an existing claim, or if your business has been impacted by the BP oil spill, it is not... Read More

Posted in Current Cases, firm-news |

Steroid Injections Linked to Fungal Meningitis Outbreak

October 10th, 2012

Methylprednisolone acetate, a steroid injection used to treat back pain, has caused an outbreak of rare fungal meningitis (Breaking News:  Other products by NECC, New England Compounding Center, have been cited in this FDA Alert). Meningitis is an inflammation of the lining of the brain and the spinal cord.  It cannot be passed from person to person, but this fungal infection of the spinal cord is very difficult to treat.  Symptoms may occur starting 1 to 4 weeks after the... Read More

Posted in Current Cases, firm-news |

Pendley, Baudin & Coffin, L.L.P. Pursuing EFFEXOR Birth Defect Cases Throughout The Country

July 18th, 2012

Pendley, Baudin & Coffin, L.L.P. are pursuing EFFEXOR birth defect cases throughout the country.  Christopher Coffin and Nicholas Rockforte of Pendley, Baudin & Coffin, L.L.P. along with a number of attorneys filed the first birth defect case against EFFEXOR. The case alleges the death of an Ohio infant was directly related to her mother’s ingestion of EFFEXOR.   EFFEXOR is a popular and common drug used in the treatment of depression, it is also known as generic venlafaxine HCL.  The case declares a link between birth... Read More

Posted in Current Cases, firm-news |

Household Life Insurance Company Improperly Denying Credit Disability Insurance Benefits

May 9th, 2012

Pendley, Baudin & Coffin Law Firm, LLP is investigating claims of Household Life Insurance Company improperly denying credit disability insurance benefits.  Household Life Insurance Company is a subsidiary of HSBC.  Household Life Insurance Company primarily sells its credit disability insurance through other subsidiaries of HSBC, including Beneficial Mortgage Company and Mortgage One Corporation d/b/a HFC Mortgage Corporation.  The credit disability insurance is routinely sold during a mortgage closing.  The credit disability insurance appears to pay the policyholder’s mortgage each month... Read More

Posted in Current Cases, firm-news |

First EFFEXOR Birth Defect Case Filed

February 10th, 2012

FIRST EFFEXOR® BIRTH DEFECT COMPLAINT FILED IN PHILADELPHIA Pregnant Mother Ingests Anti-Depressant Drug; Infant Dies PHILADELPHIA – Feb. 9, 2012 – Today, in the Philadelphia Court of Common Pleas, six attorneys from across the country filed what is believed to be the first birth defect case against EFFEXOR®, a popular and common drug used in the treatment of depression. Alleging the death of an Ohio infant was directly related to her mother’s ingestion of EFFEXOR®, the young girl’s parents are... Read More

Posted in Current Cases |

Medtronic, Manufacturer Of Infuse, Failed To Disclose Serious Side Effects

January 3rd, 2012

Medtronic, manufacturer of Infuse, failed to disclose serious and potentially life-threatening side effects.  Infuse is often used in spinal fusion operations in which spinal vertebrae are fused together to reduce back pain; it is a bioengineered material that spurs bone growth.  It as reported that in none of the 13 trials funded by Medtronic were any adverse events disclosed.  It has been reported that up to 50 percent of patients  who received Infuse suffered side effects including infection, pain, cyst... Read More

Posted in Current Cases |

© 2013 Pendley, Baudin & Coffin, L.L.P. All rights reserved.